GSK2798745
- Generic Name
- GSK2798745
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C25H28N6O3
- CAS Number
- 1419609-94-1
- Unique Ingredient Identifier
- 63FJ7LF55O
- Background
GSK2798745 is under investigation in clinical trial NCT03372603 (A Study to Assess the Effectiveness and Side Effects of GSK2798745 in Participants With Chronic Cough).
- Associated Conditions
- -
- Associated Therapies
- -
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2798745 in Participants With Diabetic Macular Edema
- First Posted Date
- 2020-03-03
- Last Posted Date
- 2024-11-08
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 16
- Registration Number
- NCT04292912
- Locations
- 🇳🇿
GSK Investigational Site, Christchurch, New Zealand
Effects of GSK2798745 on Alveolar Barrier Disruption in a Segmental Lipopolysaccharide (LPS) Challenge Model
Phase 1
Terminated
- Conditions
- Interventions
- First Posted Date
- 2018-04-27
- Last Posted Date
- 2021-03-29
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 47
- Registration Number
- NCT03511105
- Locations
- 🇩🇪
GSK Investigational Site, Hannover, Niedersachsen, Germany
A Study to Assess the Effectiveness and Side Effects of GSK2798745 in Participants With Chronic Cough
- First Posted Date
- 2017-12-13
- Last Posted Date
- 2019-10-02
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 17
- Registration Number
- NCT03372603
- Locations
- 🇬🇧
GSK Investigational Site, North Shields, United Kingdom
A Study to Evaluate the Effect of the Transient Receptor Potential Vanilloid 4 (TRPV4) Channel Blocker, GSK2798745, on Pulmonary Gas Transfer and Respiration in Patients With Congestive Heart Failure
- First Posted Date
- 2015-07-15
- Last Posted Date
- 2018-09-05
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 11
- Registration Number
- NCT02497937
- Locations
- 🇺🇸
GSK Investigational Site, Rochester, Minnesota, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath